Ixovex-1 Single Agent and Combination Therapy

Clinical trial NCT06549946 · RECRUITING

Trial details

NCT number: NCT06549946
Sponsor: Psivac Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Head and Neck Cancer

Start date: 2024-12-17
Primary completion: 2027-01-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.